United States Antimony Corp (UAMY) financial statements: income statement, balance sheet and cash flow
United States Antimony Corp's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), United States Antimony Corp reported revenue of $39.3M and net income of ($4.3M) (-150.1% year on year).
Income statement
United States Antimony Corp income statement, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Revenues
$39.3M
—
—
—
Cost of revenues
$29.4M
$11.5M
$12.0M
$9.0M
Gross profit
$9.9M
$3.5M
($3.3M)
$2.0M
General and administrative
$3.1M
$2.1M
$1.6M
$658.2K
Salaries and benefits
$11.6M
$2.4M
$639.2K
$481.1K
Professional fees
$2.4M
$968.8K
$643.2K
$302.9K
Loss on sale or disposal of property, plant and equipment, net
$51.4K
$11.1K
$217.9K
—
Gain on lease termination
($469.8K)
—
—
—
Other operating expenses
$1.7M
$475.0K
$581.6K
—
Total operating expenses
$18.3M
$5.9M
$3.7M
$1.6M
Loss from operations
($8.5M)
($2.4M)
($7.1M)
$348.2K
Interest and investment income
$810.5K
—
—
—
Unrealized gain on investment in equity securities
$3.3M
—
—
—
Other miscellaneous income (expense), net
($12.7K)
($36.1K)
$69.9K
$96.5K
Total other income, net
$4.1M
$660.4K
$720.7K
—
Loss before income taxes
($4.3M)
($1.7M)
($6.3M)
$444.7K
Income tax expense
$0
$0
$0
—
Net loss
($4.3M)
($1.7M)
($6.3M)
$428.7K
Preferred dividends
($7.5K)
$7.5K
($7.5K)
($47.3K)
Net loss available to common shareholders
($4.3M)
($1.7M)
($6.4M)
$381.4K
Basic (in dollars per share)
-$0.04
-$0.02
-$0.06
—
Diluted (in dollars per share)
-$0.04
-$0.02
-$0.06
—
Basic (in shares)
123.6M
108.6M
—
—
Diluted (in shares)
123.6M
108.6M
107.6M
—
United States Antimony Corp income statement, quarters
Line item
Jun 30, 2026 · Q2
Mar 31, 2026 · Q1
Sep 30, 2025 · Q3
Jun 30, 2025 · Q2
Revenues
$7.9M
$6.8M
$8.7M
—
Cost of revenues
$7.3M
$5.7M
$6.7M
$7.7M
Gross profit
$583.3K
$1.1M
$2.0M
$2.8M
General and administrative
$1.6M
$1.3M
$882.9K
$843.0K
Salaries and benefits
$4.2M
$5.9M
$4.9M
$1.4M
Professional fees
$1.1M
$1.3M
$522.5K
$536.9K
Other operating expenses
$640.0K
$135.7K
$1.1M
$73.2K
Total operating expenses
$7.6M
$8.6M
$6.9M
$2.8M
Income (loss) from operations
($7.0M)
($7.5M)
($4.9M)
$20.0K
Interest and investment income
$425.6K
$328.3K
($150.6K)
—
Unrealized gain on investment in equity securities
$6.8M
($4.1M)
—
—
Other miscellaneous income (expense), net
($64.2K)
($28.0K)
$21.9K
$151
Total other income (expense), net
$7.1M
($3.8M)
$136.5K
$161.5K
Income (loss) before income taxes and equity in loss of joint venture
$166.8K
($11.3M)
—
—
Income tax expense
$0
—
$0
$0
Income (loss) before equity in losses of joint venture
$166.8K
($11.3M)
—
—
Equity in losses of joint venture
($56.5K)
($16.1K)
—
—
Net income (loss)
$110.3K
($11.3M)
($4.8M)
$181.6K
Preferred dividends
($1.9K)
($1.9K)
($1.9K)
($1.9K)
Net income (loss) available to common shareholders
$108.4K
($11.3M)
($4.8M)
$179.7K
Basic (in shares)
146.6M
141.6M
123.4M
118.3M
Diluted (in shares)
151.8M
141.6M
123.4M
127.2M
Balance sheet
United States Antimony Corp balance sheet, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Cash and cash equivalents
$30.5M
$18.2M
$11.9M
$19.1M
Investment in debt securities held to maturity
$4.6M
—
—
—
Accounts receivable, net
$4.2M
$1.2M
$625.3K
$784.5K
Inventories
$12.5M
$1.2M
$1.4M
—
Prepaid expenses and other current assets
$434.8K
$104.2K
$92.4K
$137.6K
Note receivable
$2.5M
—
—
—
Total current assets
$54.7M
$20.7M
$14.1M
$21.6M
Property, plant and equipment, net
$42.4M
$12.9M
$13.5M
$12.1M
Operating lease right-of-use assets
$48.1K
$565.3K
—
—
Investment securities held to maturity - noncurrent
$15.8M
—
—
—
Investment in equity securities
$40.5M
—
—
—
Restricted cash for reclamation bonds
$162.8K
—
—
—
IVA receivable and other assets, net
$330.2K
$408.5K
$509.2K
$897.7K
Total assets
$153.9M
$34.6M
$28.1M
$34.7M
Accounts payable
$6.9M
$1.5M
$456.9K
$628.8K
Accrued liabilities
$2.9M
$1.4M
$133.8K
$201.1K
Current portion of operating lease liabilities
$34.1K
$626.6K
—
—
Current portion of long-term debt
$136.9K
$132.3K
$28.4K
$94.2K
Total current liabilities
$10.2M
$4.0M
$897.5K
$2.2M
Operating lease liabilities, net of current portion
$14.0K
$129.0K
—
—
Long-term debt, net of current portion
$58.5K
$195.4K
$0
—
Asset retirement obligations
$2.7M
$1.7M
$1.6M
$332.0K
Total liabilities
$13.0M
$6.0M
$2.6M
$2.8M
Preferred stock
$9.3K
$9.3K
$9.3K
$26.2K
Common stock, $0.01 par value, 250,000,000 shares authorized; 140,042,270 and 112,951,317 shares issued and outstanding, respectively
1.4M
1.1M
1.1M
1.1M
Treasury stock (149,639 and no shares of common stock at cost, respectively)
-574.2K
—
—
—
Additional paid-in capital
$185.6M
$68.6M
$63.9M
$64.1M
Accumulated deficit
($45.5M)
($41.1M)
($39.4M)
($33.1M)
Total stockholders' equity
$141.0M
$28.6M
$25.5M
$31.9M
Total liabilities and stockholders' equity
$153.9M
$34.6M
$28.1M
$34.7M
United States Antimony Corp balance sheet, quarters
Line item
Jun 30, 2026
Mar 31, 2026
Sep 30, 2025
Jun 30, 2025
Cash and cash equivalents
$41.4M
$3.2M
$18.3M
$5.7M
Investment in debt securities held to maturity
$4.7M
$4.6M
—
—
Accounts receivable, net
$2.6M
$2.5M
$1.9M
$2.5M
Inventories
$21.6M
$22.0M
$8.4M
$6.8M
Prepaid expenses and other current assets
$2.3M
$734.6K
$1.9M
$1.4M
Note receivable
$4.0M
$2.4M
—
—
Total current assets
$76.6M
$48.4M
$31.8M
$17.7M
Property, plant and equipment, net
$53.4M
$46.7M
$28.1M
$19.7M
Operating lease right-of-use assets
$29.3K
$38.2K
$36.3K
$275.6K
Investment in debt securities held to maturity - noncurrent
$16.1M
$15.9M
—
—
Investment in equity securities
$43.2M
$36.4M
—
—
Investment in joint venture
$76.4K
$83.9K
—
—
Restricted cash
$820.6K
$163.8K
—
—
Other assets, net
$330.2K
$330.2K
$908.6K
$891.9K
Total assets
$190.6M
$148.0M
$79.9M
$47.5M
Accounts payable
$3.9M
$9.7M
$4.2M
$5.7M
Accrued liabilities
$2.4M
$3.4M
$1.6M
$1.3M
Current portion of operating lease liabilities
$19.9K
$27.5K
$29.0K
$592.7K
Current portion of long-term debt
$175.9K
$138.1K
$135.8K
$134.6K
Total current liabilities
$6.6M
$13.4M
$6.3M
$8.0M
Operating lease liabilities, net of current portion
$9.4K
$10.7K
$7.3K
$117.7K
Long-term debt, net of current portion
$158.9K
$23.5K
$93.2K
$127.5K
Asset retirement obligations
$2.8M
$2.8M
$1.8M
$1.8M
Total liabilities
$9.6M
$16.2M
$8.1M
$10.0M
Preferred stock
$9.3K
$9.3K
$9.3K
$9.3K
Common stock, $0.01 par value, 250,000,000 shares authorized; 150,521,555 and 140,042,270 shares issued, respectively
1.5M
1.4M
1.3M
1.2M
Treasury stock (1,050,186 and 149,639 shares of common stock at cost, respectively)
-9.4M
-6.4M
-510.7K
—
Additional paid-in capital
$245.6M
$193.6M
$116.2M
$76.7M
Accumulated deficit
($56.7M)
($56.8M)
($45.2M)
($40.4M)
Total stockholders' equity
$181.0M
$131.9M
$71.8M
$37.5M
Total liabilities and stockholders' equity
$190.6M
$148.0M
$79.9M
$47.5M
Cash flow statement
United States Antimony Corp cash flow statement, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Net loss
($4.3M)
($1.7M)
($6.3M)
—
Depreciation and amortization
$1.2M
$1.1M
$959.4K
$909.2K
Accretion of asset retirement obligation
$77.9K
$73.1K
$13.5K
$17.8K
Noncash operating lease expense
$289.5K
$222.2K
—
—
Share-based compensation
$7.1M
$568.6K
—
—
Accretion income from investment in debt securities held to maturity
($416.0K)
—
—
—
Loss on sale or disposal of property, plant and equipment, net
$51.4K
$11.1K
—
—
Gain on lease termination
($469.8K)
—
—
—
Write-down of inventory to net realizable value
$919.1K
$65.6K
$2.1M
$277.1K
Change in allowance for credit losses
($9.3K)
$261.0K
—
—
Unrealized gain on investment in equity securities
($3.3M)
—
—
—
Change in IVA receivable reserve
$1.3M
$100.7K
—
—
Accounts receivable
($3.1M)
($270.3K)
($80.6K)
$47.5K
Inventories
($12.2M)
$74.7K
($2.1M)
($596.8K)
Prepaid expenses and other current assets
($283.9K)
($11.8K)
$45.2K
($137.6K)
IVA receivable and other assets, net
($1.2M)
—
($299.1K)
—
Accounts payable
$3.4M
$1.1M
($171.9K)
($756.9K)
Accrued liabilities
$1.4M
$1.3M
($67.3K)
($72.6K)
Accrued liabilities - directors
$2.6K
$16.5K
$51.8K
—
Net cash (used in) provided by operating activities
($9.7M)
$2.2M
($4.8M)
($249.3K)
Purchases of investment in debt securities held to maturity
($19.9M)
—
—
—
Purchases of equity investment securities
($37.2M)
—
—
—
Issuance of note receivable
($2.5M)
—
—
—
Proceeds from sales or disposals of property, plant and equipment
$13.4K
$315.6K
—
—
Purchases of property, plant and equipment
($27.8M)
($430.6K)
($1.5M)
($1.7M)
Net cash used in investing activities
($87.4M)
($42.1K)
($1.3M)
($1.8M)
Principal payments on long-term debt
($132.3K)
($103.5K)
($283.6K)
—
Proceeds from exercises of stock options
$117.7K
—
—
—
Acquisition of treasury stock related to equity awards
($449.5K)
—
$0
($203.0K)
Proceeds from issuance of common stock, net of issuance costs
$104.2M
$2.8M
—
—
Proceeds from exercise of warrants
$5.7M
—
—
$0
Net cash provided by financing activities
$109.5M
$4.1M
($1.1M)
($267.7K)
NET INCREASE IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH
$12.4M
$6.3M
($7.2M)
($2.3M)
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF PERIOD
$18.3M
$12.0M
$19.1M
$21.4M
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT END OF PERIOD
$30.7M
$18.3M
—
—
Interest paid in cash
$16.7K
$8.9K
$10.5K
$15.1K
Recognition of operating lease liability and right-of-use asset
$86.2K
$787.5K
—
—
Property and equipment included in accounts payable
$2.0M
—
—
—
United States Antimony Corp cash flow statement, quarters
Line item
Jun 30, 2026 · YTD
Mar 31, 2026 · Q1
Sep 30, 2025 · YTD
Jun 30, 2025 · YTD
Net income (loss)
($11.2M)
($11.3M)
($4.1M)
$728.1K
Depreciation and amortization
$925.8K
$410.5K
$839.4K
$559.5K
Accretion of asset retirement obligation
$65.0K
$32.5K
$58.4K
$39.0K
Share-based compensation
$7.7M
$4.8M
$4.7M
$832.3K
Accretion income from investment securities held to maturity
($386.6K)
($192.1K)
($222.4K)
($96.0K)
Paid-in-kind interest from notes receivable
($127.3K)
($45.8K)
—
—
Gain on sale or disposal of property, plant and equipment, net
($1.9K)
($1.9K)
($8.7K)
—
Equity in losses of joint venture
$72.6K
$16.1K
—
—
Write-down of inventory to net realizable value
$161.5K
$161.5K
—
$0
Change in allowance for credit losses
$436
$156
$5.8K
$884
Unrealized gain on investment in equity securities
($2.7M)
$4.1M
—
—
Accounts receivable
$1.6M
$1.7M
($804.2K)
($1.4M)
Inventories
($9.6M)
($9.7M)
($7.2M)
($5.6M)
Prepaid expenses and other current assets
($1.9M)
($299.7K)
($1.7M)
($1.2M)
Accounts payable
($4.5M)
($2.2M)
$2.7M
$4.2M
Accrued liabilities
($896.6K)
$450.4K
$154.5K
($175.4K)
Accrued liabilities - directors
($15.1K)
($3.0K)
($51.8K)
($52.5K)
Net cash used in operating activities
($20.7M)
($12.1M)
($6.2M)
($2.4M)
Proceeds from maturity of debt securities held to maturity
$1.3M
—
—
—
Purchases of debt securities held to maturity
($1.3M)
—
—
—
Proceeds from note receivable principal payment
$100.0K
$100.0K
—
—
Additional advance under convertible note receivable
($1.1M)
—
—
—
Proceeds from sales of property, plant and equipment
$1.9K
$1.9K
$8.7K
$500
Investment in joint venture
($149.0K)
($100.0K)
—
—
Proceeds from government grant related to capital expenditures
$12.8M
—
—
—
Purchases of property, plant and equipment
($22.8M)
($12.6M)
($16.1M)
($7.4M)
Net cash used in investing activities
($11.1M)
($12.6M)
($36.0M)
($17.4M)
Principal payments on long-term debt
($71.8K)
($33.8K)
($98.8K)
($65.5K)
Proceeds from exercises of stock options
$259.5K
$48.6K
$55.0K
$55.0K
Treasury stock acquired
($7.8M)
($5.0M)
($409.2K)
—
Proceeds from issuance of common stock, net of issuance costs
$49.1M
$1.3M
$38.4M
$5.1M
Proceeds from exercise of warrants
$2.0M
$994.8K
$4.4M
—
Net cash provided by financing activities
$43.4M
($2.6M)
$42.4M
$7.3M
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH
$11.6M
($27.3M)
$199.2K
($12.5M)
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF PERIOD
$30.7M
$30.7M
$18.3M
$18.3M
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT END OF PERIOD
$42.3M
$3.4M
$18.5M
$5.8M
Interest paid in cash
$64.4K
$1.7K
$14.6K
$5.2K
Equipment purchased with note payable
$211.1K
—
—
$0
Property and equipment included in accounts payable / accrued liabilities